Marker Therapeutics Inc (MRKR)

NASDAQ

Currency in USD

MRKR Pro Research

1.140

-0.090(-7.32%)

Closed·15:59:59

After Hours

1.1400.000(0.00%)

·16:10:04

Fair Value

Unlock Value

Day's Range

1.100

1.265

52 wk Range

0.810

2.460

MRKR Income Statement

Assess the Marker Therapeutics income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the MRKR net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

1.24

3.51

3.31

6.59

3.55

Total Revenues Growth

aa.aa

+166.01%

+182.96%

-5.76%

+99.06%

-46.19%

Cost Of Revenues

aa.aa

27.79

11.97

10.42

13.47

11.8

Gross Profit

aa.aa

-26.55

-8.45

-7.11

-6.88

-8.25

Gross Profit Growth

aa.aa

-44.2%

+68.16%

+15.96%

+3.22%

-20.01%

Gross Profit Margin %

aa.aa

-2,138.44%

-240.64%

-214.6%

-104.33%

-232.68%

Other Operating Expenses, Total

aa.aa

12.92

11.34

7.48

4.24

4.18

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+23.42%	-12.29%	-34.05%	-43.26%	-1.34%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	12.92	11.34	7.48	4.24	4.18
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-39.48

-19.79

-14.58

-11.12

-12.44

Operating Income Growth

aa.aa

-36.67%

+49.87%

+26.32%

+23.75%

-11.86%

EBIT Margin %

aa.aa

-3,179.32%

-563.28%

-440.37%

-168.69%

-350.68%

Net Interest Expenses

aa.aa

0.01

0.25

0.54

0.44

0.59

Net Interest Expenses Growth

aa.aa

-96.17%

+4,251.98%

+117.35%

-18.95%

+35.97%

Interest Expense, Total

aa.aa

Interest And Investment Income

aa.aa

0.01

0.25

0.54

0.44

0.59

Other Non Operating Expenses, Total

aa.aa

0.12

EBT, Excl. Unusual Items

aa.aa

-39.47

-19.54

-14.04

-10.68

-11.73

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-2.41

-0.23

-0.45

EBT, Incl. Unusual Items

aa.aa

-41.88

-19.78

-14.04

-10.68

-12.18

EBT, Incl. Unusual Items Growth

aa.aa

-45.89%

+52.78%

+28.99%

+23.93%

-14.02%

EBT, Incl. Unusual Items Margin

aa.aa

-3,372.68%

-562.85%

-424.09%

-162.06%

-343.39%

Income Tax Expense

aa.aa

0.05

-0.02

Net Income to Company

aa.aa

-41.88

-29.93

-8.24

-10.73

-12.16

Minority Interest

aa.aa

Net Income

aa.aa

-41.88

-29.93

-8.24

-10.73

-12.16

Net Income Growth

aa.aa

-45.89%

+28.53%

+72.48%

-30.28%

-13.35%

Net Income Margin %

aa.aa

-3,372.68%

-851.87%

-248.76%

-162.82%

-342.96%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-41.88

-19.78

-14.05

-10.73

-12.16

Basic EPS - Continuing Operations

aa.aa

-5.47

-2.37

-1.59

-1.19

-0.79

Basic EPS - Continuing Operations Growth

aa.aa

+10.3%

+56.74%

+32.67%

+25.05%

+33.52%

Diluted EPS - Continuing Operations

aa.aa

-5.47

-2.37

-1.59

-1.19

-0.79

Diluted EPS - Continuing Operations Growth

aa.aa

+10.3%

+56.7%

+32.72%

+25.05%

+33.52%

Basic Weighted Average Shares Outstanding

aa.aa

7.65

8.35

8.81

8.98

15.31

Diluted Weighted Average Shares Outstanding

aa.aa

7.65

8.35

8.81

8.98

15.31

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-37.33

-17

-11.79

EBITDA Growth

aa.aa

-31.44%

+54.45%

+30.64%

EBITDA Margin %

aa.aa

-3,006.26%

-483.9%

-356.14%

EBIT

aa.aa

-39.48

-19.79

-14.58

-11.12

-12.44

* In Millions of USD (except for per share items)

FAQ

What was Marker Therapeutics’s revenue at year end?

At the end of the last reported fiscal year, Marker Therapeutics (MRKR) recorded total revenue of 3.547 million USD.

What was Marker Therapeutics’s net income for the year?

For the full year, Marker Therapeutics reported net income of -12.164 million USD.

How much net income did Marker Therapeutics post in the last quarter?

In the most recent quarter, Marker Therapeutics (MRKR) posted net income of -3.179 million USD.

What was Marker Therapeutics’s gross profit for the year?

Gross profit for the year was reported at -8.252 million USD.

How much gross profit did Marker Therapeutics generate last quarter?

Marker Therapeutics recorded gross profit of -2.843 million USD in its latest quarterly report.

What was Marker Therapeutics’s annual operating income?

For the full year, Marker Therapeutics (MRKR) reported operating income of -12.437 million USD.

What was Marker Therapeutics’s operating income last quarter?

Quarterly operating income was -4.073 million USD.

What was the quarter-over-quarter change in gross profit for Marker Therapeutics?

In the latest quarter, gross profit changed by -174.027% million USD from the previous quarter.

S&P/TSX

36,146.42

+344.83

+0.96%

S&P/TSX 60

2,130.75

+21.17

+1.00%

US 30

54,414.60

+328.7

+0.61%

US 500

7,733.20

-3.3

-0.04%

S&P 500 VIX

15.81

-0.69

-4.18%

DAX

26,126.30

-76.05

-0.29%

Dollar Index

99.55

-0.190

-0.19%

Market Movers

Name	Last	Chg. %	Vol.
Toronto Dominion Bank	169.65	+1.04%	7.23M
Bank of Montreal	253.29	+0.09%	4.73M
Enbridge	72.71	-3.17%	13.99M
Shopify Inc	201.97	+16.47%	4.98M
RBC	295.95	+0.85%	3.38M
Manulife Financial	62.44	-0.86%	10.98M
Suncor Energy	88.12	-2.94%	6.51M

Name	Last	Chg. %	Vol.
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Digicann Ventures	0.010	+100.00%	2.00K
EnviroMetal Technologies	0.01	+100.00%	1.00K
Spacefy	0.020	+100.00%	22.00K
James Bay Resources Ltd	0.020	+100.00%	1.47K
Enerev5 Metals	0.0100	+100.00%	9.50K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.05	-68.75%	18.17K
Pharmadrug	0.0050	-50.00%	66.29K
Albert Labs International	0.005	-50.00%	1.00K
Biosenta Inc	0.035	-50.00%	8.50K
Verisante Technology Inc	0.0050	-50.00%	1.00K
CardioComm Solutions Inc.	0.0050	-50.00%	24.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	13.75	+2.69%	24.97M
Keel Infra	5.52	-4.66%	2.51M
Canadian Natural	62.85	-3.20%	5.53M
Hut 8	129.870	-8.77%	495.77K
Celestica Inc.	508.54	-2.90%	234.61K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaaaaaaaa A	101.80	+49.40%	152.09
Aaa A	5.30	+46.39%	7.76
A Aaaaaaaaaaaa	145.30	+40.56%	204.23
Aaaa Aa	20.13	+40.41%	28.26
Aaaaaa	22.34	+40.30%	31.34
Aaaa Aaa	14.80	+39.34%	20.62
Aaaaaaaaaaaaaaaaa	13.75	+38.15%	19.00

Name	Last	Upside	Fair Value
Aa Aaaaaaaaaaaaa A	101.80	+49.40%	152.09
Aaa A	5.30	+46.39%	7.76
A Aaaaaaaaaaaa	145.30	+40.56%	204.23
Aaaa Aa	20.13	+40.41%	28.26
Aaaaaa	22.34	+40.30%	31.34
Aaaa Aaa	14.80	+39.34%	20.62
Aaaaaaaaaaaaaaaaa	13.75	+38.15%	19.00

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Marker Therapeutics Inc (MRKR)

MRKR Income Statement

FAQ

What was Marker Therapeutics’s revenue at year end?

What was Marker Therapeutics’s net income for the year?

How much net income did Marker Therapeutics post in the last quarter?

What was Marker Therapeutics’s gross profit for the year?

How much gross profit did Marker Therapeutics generate last quarter?

What was Marker Therapeutics’s annual operating income?

What was Marker Therapeutics’s operating income last quarter?

What was the quarter-over-quarter change in gross profit for Marker Therapeutics?

Trending Stocks